O.V. SHILOVSKIKH¹, V.N. KAZAYKIN¹, V.O. PONOMARYOV¹, T.N. NOVOSELOVA¹, A.Yu. KLEYMENOV¹, V.G. KAZANTSEV¹, O.A. MARKINA², A.V. DZHAPAKOVA²

¹Ekaterinburg Eye Microsurgery Center, 4a Academician Bardin Str., Ekaterinburg, Russian Federation, 620149

²Sverdlovsk Regional Clinical Hospital №1, 185 Volgogradskaya Str., Ekaterinburg, Russian Federation, 620102

 Shilovskikh O.V. ― Cand. Med. Sc., Director General, ophthalmosurgeon, tel. (343) 231-00-00, e -mail: lazer@eyeclinic.ru

Kazaykin V.N. ― D. Med. Sc., Head of Vitreoretinal Surgery Department, ophthalmosurgeon, tel. +7-912-288-53-37, e-mail: victor-ru66@mail.ru

Ponomaryov V.O. ― ophthamosurgeon of the Vitreoretinal Surgery Department, tel. +7-922-106-00-32, e-mail: ponomarev-mntk@mail.ru

Novoselova T.N. ― ophthalmologist of the Department of Functional Diagnostics and Medical Control, tel. +7-912-626-43-60, e-mail: novoselova0708@gmail.com

Kleymenov A.Yu. ― ophthalmosurgeon of the Vitreoretinal Surgery Department., tel. +7-922-610-57-83, e-mail: kley_82@mail.ru

Kazantsev V.G. ― epidemiologist, tel. (343) 231-01-12, e-mail: valery@eyeclinic.ru

Markina O.A. ― bacteriologist, tel. (343) 351-15-43, e-mail: o.a.markina@mail.ru

Dzhapakova A.V. ― bacteriologist, tel. (343) 351-15-43, e-mail: фzhapakovaI73@yandex.ru

The article presents the results of investigations of 66 eyes of 33 patients who underwent cataract surgery with intraocular lens implantation in one eye (main group); fellow eyes of the same patients made up the control group. Laboratory and clinical investigations were performed to assess the efficacy of 3rd generation fluoroquinolones instillations as pre-operation preparation. No significant difference was found between the main and control groups in the quantitative and qualitative composition of conjunctival microflora.

Key words: antibacterial drugs, conjunctival microflora, preoperative prophylaxis.

REFEENCES

1. Mino de Kaspar H., Chang R.T., Shriver E.M. et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology, 2004, no. 111, pp. 1352-5.
2. Inoue Y. Multicentre study of levofloxacin pre-operative use in Japan. Eurotimes, 2006, vol. 11, pp. 5-6.
3. Suzuki T., Tanaka H., Toriyama K. et al. Prospective clinical evaluation of 1.5% levofloxacin ophthalmic solution in ophthalmic perioperative disinfection. Journal of Ocular Pharmacology and Therapeutics, 2013, no. 29(10), pp. 887-92.
4. ESCRS Endophthalmitis Study Group: Prophylaxis of post-operative endophthalmitis following cataract surgery: results of the ESCRS multi-centre study and identification of risk factors. Cataract Refract. Surg., 2007, Vol. 33, no. 6, pp. 978-988
5. He L., Ta C.N., Hu N., et al. Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjuncctival bacteria. J Ocul Pharmacol Ther, 2009, no. 25, pp. 373-8.
6. Moss J.M., Sanislo S.R., Ta C.N. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology, 2009. no. 116, pp. 1498-501
7. Miño de Kaspar H., Kreutzer T.C., Aguirre-Romo I., et al. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. American Journal of Ophthalmology, 2008, no. 145(1), pp. 136-142.
8. Halachmi-Eyal., Land Y., Keness Y., et al. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. Following Cataract Surgery, 2009 no. 35(12), pp. 2109-14
9. Li B., Nentwich M.M., Hoffmann L.E., et al. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% aspreoperative prophylaxis in cataract surgery. Journal of Cataract & Refractive Surgery, 2013, no. 39(7), pp. 994-1001.
10. Quiroga L.P., Lansingh V., Laspina F., et al. A prospective study demonstrating the effect of 5% povidone-iodine application for anterior segment intraocular surgery in Paraguay. Arquivos Brasileiros de Oftalmologia, 2010, no. 73(2), pp. 125-8.
11. Wu P.C., Li M., Chang S.J., et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone- iodine preoperative Journal of Ocular Pharmacology and Therapeutics, 2006, no. 22(1), pp. 54-61.
12. Trinavarat A., Atchaneeyasakul L.O., Nopmaneejumruslers C., et al. Reduction of endophthalmitis rate after cataract surgery with preoperative 5% povidone-iodine. Dermatology, 2006, no. 212 Suppl 1, pp. 35-40.
13. Friling E., Lundström M., Stenevi , et al. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg, 2013, no. 39, pp. 15-21.
14. Fernández-Rubio M.E., Cuesta-Rodríguez T., Urcelay-Segura J.L., et al. Spectrum and susceptibility of preoperative conjunctival bacteria. Archivos de la Sociedad Española de Oftalmología, 2013, no. 88(12), pp.458-65.
15. Fernández-Rubio E., Urcelay JL., Cuesta-Rodriguez T. The antibiotic resistance pattern of conjunctival bacteria: a key for designing a cataract surgery prophylaxis. Eye (Lond) , 2009, no. 23(6), pp. 1321-8.
16. Park Y.,Kim K.S., Park Y.H.  et al.  Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics. Journal of Ocular Pharmacology and Therapeutics, 2013, no. 29(10), pp. 900-5.
17. Dev S., Pulido J.S., Tessler H.H., et al. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology, 1999, Vol. 106, pp. 774 – 781.
18. Jabbarvand M., Hashemian H., Khodaparast M., et al. Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors. Ophthalmology, 2016, no. 123(2), pp. 295-301.
19. Landré C.,Baillif S. Endogenous bacterial and fungal endophthalmitis at Nice University Medical Center: A 15-year case review. Journal Français D’Ophtalmologie, 2016, no. 39(4), pp. 346-54.
20. Jackson T.L., Paraskevopoulos T., Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Survey of Ophthalmology, 2014, no. 59(6), pp. 627-35.
21. Asencio-Egea M.A.,Huertas-Vaquero M., Carranza-González R. et al. Endogenous endophthalmitis: case report and brief review of a serious ocular disease. Rev Chilena Infectol, 2013, no. 30(5), pp. 516-21.
22. Lim H.W., Shin J.W., Cho H.Y., et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina,2014, no. 34(3), pp. 592-602.
23. Fernández-Rubio M.E., Cuesta-Rodríguez T., Urcelay-Segura J.L., et al. Pathogenic conjunctival bacteria associated with systemic co-morbidities of patients undergoing cataract surgery. Eye (Lond), 2013, no. 27(8), pp. 915-23.
24. Barry P., Cordoves L., Gardner ESCRS Guidelines for Prevention and Treatment of Endopthalmitis Following Cataract Surgery. Co Dublin: Temple House, Temple Road, Blackrock, 2013. –P.15
25. Huang Y., Zhan Y., Xie L. Clinical observations of acuteonset endophthalmitis after clear corneal phacoemulsification. [Zhonghua yan ke za zhi]. Chinese journal of ophthalmology, 2015, no. 51(12), pp. 918-23.
26. ESCRS Endophthalmitis Study Group: Prophylaxis of post-operative endophthalmitis following cataract surgery, 2013, Vol. 8, 13 p.
27. Zeckel M.L. A closer look at vancomycin, teicoplanin, and antibmicrobial resitance. J Chemother, 1997, no. 9(5), pp. 311-31, discussion 332-5.
28. Bereznyakov I.G. [New opportunities of therapeutic application of a levofloxacin] Novye vozmozhnosti terapevticheskogo primenenija levofloksacina, Antibiotikoterapija, [Antibiotic treatment], 2010, 4 (233), pp. 42-43. (in Russ).
29. Vohmyakov A.V., Okolov I.N., Gurchenok P.A. [The choice of an optimum antibiotic for prophylaxis of infectious complications in an ophthalmosurgery] Vybor optimal’nogo antibiotika dlja profilaktiki infekcionnyh oslozhnenij v oftal’mohirurgii, Klinicheskaja Oftal’mologija, [Clinical Ophthalmology], no. 1, 2007. 36 p. (in Russ).
30. Masket S., Hovanesian J., Raizman M., et al. Use of a calibrated force gauge in clear corneal cataract surgery to quantify point-pressure manipulation. J Cataract Refract Surg, 2013, no. 39(4), pp. 511-8.
31. Wallin T., Parker J., Jin Y., et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg, 2005, no. 31(4), pp. 735-41.